Lyophilization

Breaking News | Fill/Finish | Industry News | Lyophilization

Societal CDMO Initiates New Fill/Finish and Lyo Project at San Diego Facility

To support a client's ongoing clinical development of a compound as a potential treatment for solid tumors.

06.08.22

Breaking News | Formulation Development | Industry News | Lyophilization | Methods Development

Berkshire Sterile Adds Formulation, Lyophilization, Method Development Services

Now offers first-in-human formulation development, supply material for preclinical studies, and conduct research-level stability studies.

05.16.22

PCI Pharma Services Unveils Major Manufacturing Expansion

$100 million investment in New England expands sterile lyophilization and liquid filling capabilities.

05.10.22

Biologics and Vaccine Production Drive Parenteral Market

Mike Babics of Alcami discusses key market trends and investments, vaccine development and production needs, and advances in the parenteral space.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.30.22

cGMP Manufacture | Fill/Finish | Lyophilization | Parenterals

Industry Invests Billions in Parenteral Capabilities

Market opportunities have service providers making significant investments via acquisitions, expansion of services and capacities.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.11.22

Breaking News | Fill/Finish | Industry News | Lyophilization

Curia Enters Agreement with U.S. Govt. to Expand Sterile Fill-Finish Capability

The 65,000-sq.-ft. expansion includes two 430-sq.-ft. lyophilizers, automated visual inspection technology, automated packaging capacity, ultra-cold storage.

03.09.22

APIs | Formulation Development | Lyophilization | Methods Development

Investments in Lyophilization & Global API Manufacturing Market

API manufacturing market is expected to reach $250.7 billion in 2026 at a CAGR of 6.4%

Online Exclusives02.11.22

Breaking News | Fill/Finish | Industry News | Lyophilization

PCI Pharma Services Completes LSNE Acquisition

Adds cGMP aseptic fill-finish capabilities and expertise in lyophilization, an important manufacturing process for injectable and biologic therapies.

12.14.21

Analytical Services | Fill/Finish | Lyophilization | Vials

IDT Biologika

...

Antje Seidler, Marketing Manager 12.02.21

Breaking News | Facilities | Fill/Finish | Industry News | Lyophilization

Jubilant HollisterStier to Host Groundbreaking Ceremony for $92M Expansion

New high-speed filling line and lyophilizers will increase Spokane facility’s sterile injectable capacity by 50%.

11.12.21

Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Lyophilization

Baxter Invests $100M to Expand Sterile Fill/Finish Mfg. Facility in Germany

Adds syringe filling line, additional liquid and lyophilized vial capacity, and expands manufacturing footprint.

11.11.21

cGMP Manufacture | Fill/Finish | Injectables | Lyophilization

Adressing Demand for Injectables in Today's Market

Salim Haffar, Chief Executive Officer of PCI, discusses the motivating factors behind the LSNE acquisition and expanded capabilities and scale.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 11.08.21

Alcami, PharmaTher Enter Manufacturing Agreement

U.S.-based CDMO to manufacture PharmaTher’s ketamine products for FDA Phase 3 clinical studies and global commercialization.

10.25.21

PCI Pharma Services Acquires LSNE

Adds end-to-end global sterile fill-finish and lyophilization manufacturing capabilities.

10.13.21

Breaking News | Facilities | Industry News | Lyophilization

LSNE Doubles Lyophilization Capacity

Installation and validation completed on new large-scale freeze-dryer at Wisconsin facility.

10.12.21

Baxter BioPharma Solutions

Baxter’s BioPharma Solutions business collaborates with pharmaceutical companies to support commercialization objectives for their molecules.

Laura Salo, Associate Brand Manager 10.08.21

Breaking News | Facilities | Industry News | Lyophilization | Parenterals

Alcami Expands Parenteral Operations

$48 million investment adds 34,000 square feet and increases fill-finish and lyophilization capacity.

10.01.21

Lonza Expands Operations in China

A new drug product fill and finish manufacturing line will be installed at its Guangzhou site.

08.26.21

Biologics, Proteins, Vaccines | Drug Development | Fill/Finish | Lyophilization

VideoBites: IDT Biologika

IDT Biologika specializes in the production of innovative live viral vaccines, viral vectors for gene and immune therapeutics, oncolytic viruses and more.

Videos